Results of a Nation-Wide Survey Evaluating Psychotropic Medication Use in Fragile X Syndrome

A Comparison of Web and Mail Survey Response Rates

Kaplowitz, M. D., Hadlock, T. D., & Levine, R. (2004) · Public Opinion Quarterly · doi:10.1093/poq/nfh006 · Cited by 1,661 · see citing works

The mGluR theory of fragile X mental retardation

Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · see citing works

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP

Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · see citing works

Fragile X Syndrome: Diagnosis, Treatment, And Research

Silverman, & Cronister, A. (1991) · Johns Hopkins University Press eBooks · Cited by 481 · see citing works

Fragile X Syndrome

Hagerman, R. J. (2002) · doi:10.56021/9780801868436 · Cited by 299 · see citing works

Epilepsy in fragile X syndrome

Berry‐Kravis, E. (2002) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2002.tb00277.x · Cited by 271 · see citing works

Fragile X syndrome: diagnosis, treatment and research

Vries, B. B. A. D. (2003) · Human Genetics · doi:10.1007/s00439-002-0888-y · Cited by 163 · see citing works

A controlled trial of stimulant medication in children with the fragile X syndrome

Hagerman, R. J., Murphy, M. A., & Wittenberger, M. D. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320300138 · Cited by 158 · see citing works

Psychopharmacology in fragile X syndrome—Present and future

Berry‐Kravis, E., & Potanos, K. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20007 · Cited by 151 · see citing works

Neuropsychiatric Symptoms of Fragile X Syndrome

Tsiouris, J. A., & Brown, W. T. (2004) · CNS Drugs · doi:10.2165/00023210-200418110-00001 · Cited by 120 · see citing works

Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome

Beckel-Mitchener, A. C., & Greenough, W. T. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20009 · Cited by 82 · see citing works

Cyclic AMP metabolism in fragile X syndrome

Berry‐Kravis, E., & Huttenlocher, P. R. (1992) · Annals of Neurology · doi:10.1002/ana.410310105 · Cited by 81 · see citing works

Atypical antipsychotics in persons with developmental disabilities

Aman, M. G., & Madrid, A. (1999) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/(sici)1098-2779(1999)5:4 · Cited by 57 · see citing works

Fragile X syndrome. Molecular and clinical insights and treatment issues.

Hagerman, R. J. (1997) · Europe PMC (PubMed Central) · Cited by 34 · see citing works

A behavior-analytic conceptualization of the side effects of psychotropic medication

Valdovinos, M. G., & Kennedy, C. H. (2004) · The Behavior Analyst · doi:10.1007/bf03393182 · Cited by 30 · see citing works

Understanding the biological underpinnings of fragile X syndrome

Chiurazzi, P., Neri, G., & Oostra, B. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200312000-00003 · Cited by 29 · see citing works

Imipramine Treatment of ADHD in a Fragile X Child

Hilton, D. K., Martin, C. A., Heffron, W. M., Hall, B. D., & Johnson, G. L. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/s0890-8567(10)80024-3 · Cited by 26 · see citing works

Imipramine Treatment of ADHD in a Fragile X Child

HILTON, D. K., MARTIN, C. A., Heffron, W. M., et al. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199109000-00021 · Cited by 9 · see citing works

The Effects of a Computerized Monitoring System of Psychotropic Medication Use by People with Developmental Disabilities on Staff Reported Side Effects

Valdovinos, M. G., & Schroeder, S. R. (2003) · Journal of Developmental and Physical Disabilities · doi:10.1023/a:1026358031999 · Cited by 4 · see citing works

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works

Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment

Kaufmann, W. E., Kidd, S. A., Andrews, H. F., Budimirovic, D. B., Esler, A., Haas-Givler, B., Stackhouse, T., Riley, C., Peacock, G., Sherman, S. L., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2016-1159f · Cited by 268 · see citing works

Antipsychotic drug side effects for persons with intellectual disability

Matson, J. L., & Mahan, S. (2010) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2010.05.005 · Cited by 127 · see citing works

A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with fragile X syndrome

Greiss Hess, L., Fitzpatrick, S. E., Nguyen, D. V., Chen, Y., Gaul, K. N., Schneider, A., Lemons Chitwood, K., Eldeeb, M. A. A. A., Polussa, J., Hessl, D., et al. (2016) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000334 · Cited by 122 · see citing works

Cardiac autonomic regulation in autism and Fragile X syndrome: A review.

Klusek, J., Roberts, J. E., & Losh, M. C. (2014) · Psychological Bulletin · doi:10.1037/a0038237 · Cited by 99 · see citing works

Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross‐sectional total population study

McMahon, M. J., Hatton, C., & Bowring, D. L. (2020) · Journal of Intellectual Disability Research · doi:10.1111/jir.12775 · Cited by 81 · see citing works

Physiological Arousal in Autism and Fragile X Syndrome: Group Comparisons and Links With Pragmatic Language

Klusek, J., Martin, G. E., & Losh, M. C. (2013) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944.7558-118.6.475 · Cited by 63 · see citing works

Medication Utilization for Targeted Symptoms in Children and Adults With Fragile X Syndrome

Bailey, D. B., Raspa, M., Bishop, E. E., Olmsted, M. G., Mallya, U. G., & Berry‐Kravis, E. (2011) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e318236c0e1 · Cited by 59 · see citing works

Treatments for fragile X syndrome: A closer look at the data

Hall, S. S. (2009) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.78 · Cited by 56 · see citing works

An analysis of challenging behavior, comorbid psychopathology, and Attention-Deficit/Hyperactivity Disorder in Fragile X Syndrome

Newman, I., Leader, G., Chen, J. L., & Mannion, A. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.11.003 · Cited by 45 · see citing works

Functional analysis and treatment of problem behavior exhibited by children with fragile X syndrome

Kurtz, P. F., Chin, M. D., Robinson, A. N., O’Connor, J. T., & Hagopian, L. P. (2015) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2015.06.010 · Cited by 45 · see citing works

Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome

AlOlaby, R. R., Sweha, S. R., Silva, M., Durbin-Johnson, B. P., Yrigollen, C. M., Pretto, D. I., Hagerman, R. J., & Tassone, F. (2017) · Brain and Development · doi:10.1016/j.braindev.2017.01.012 · Cited by 41 · see citing works

How common are challenging behaviours amongst individuals with Fragile X Syndrome? A systematic review

Hardiman, R. L., & McGill, P. (2018) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2018.02.020 · Cited by 31 · see citing works

Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice

Wrenn, C. C., Heitzer, A. M., Roth, A. K., Nawrocki, L., & Valdovinos, M. G. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.11.035 · Cited by 17 · see citing works

Cortisol profiles differentiated in adolescents and young adult males with fragile X syndrome versus autism spectrum disorder

Matherly, S., Klusek, J., Thurman, A. J., McDuffie, A. S., Abbeduto, L., & Roberts, J. E. (2017) · Developmental Psychobiology · doi:10.1002/dev.21578 · Cited by 16 · see citing works

Attention/Deficit Hyperactivity Disorder in Adolescent and Young Adult Males With Fragile X Syndrome

Klusek, J., O’Connor, S. L., Hickey, A. C., Hills, K. J., Abbeduto, L., & Roberts, J. E. (2022) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-127.3.213 · Cited by 11 · see citing works

Targeted Treatments for Fragile X Syndrome

Johnson, D., Clark, C. J., & Hagerman, R. J. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-21054-9_10 · Cited by 10 · see citing works

Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs

Vigod, S. N., Lunsky, Y., Cobigo, V., Wilton, A. S., Somerton, S., & Seitz, D. P. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.116.002691 · Cited by 10 · see citing works

Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivity

Pedapati, E. V., Ethridge, L. E., Liu, Y., Liu, R., Sweeney, J. A., DeStefano, L. A., Miyakoshi, M., Razak, K. A., Schmitt, L., Moore, D. R., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0306157 · Cited by 8 · see citing works

Effects of clonidine on progressive ratio schedule performance in Fmr1 knockout mice

Wrenn, C. C., French, E. J., Baker, D., McCallian, R., Kirk, R., Reilly, M. P., & Valdovinos, M. G. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05760-8 · Cited by 4 · see citing works

Temporal and frontal lobe contributions to neural synchronization dysfunction and auditory attention in Fragile X SyndromePreprint

Pedapati, E. V., Ethridge, L. E., DeStefano, L. A., Liu, Y., Miyakoshi, M., Sweeney, J. A., Schmitt, L., Gilbert, D. L., Wu, S. W., Liu, R., et al. (2022) · medRxiv · doi:10.1101/2022.05.10.22274929 · Cited by 2 · see citing works

Acquisition of Avoidance Responding in the Fmr1 Knockout Mouse

Valdovinos, M. G., Ippolito, K., Nawrocki, L., Woods, G., & Wrenn, C. C. (2010) · Psychology · doi:10.4236/psych.2010.15045

Pragmatic language in autism and fragile X syndrome: links with physiological arousal and anxiety

Klusek, J. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/n8n8-g904 · Cited by 1 · see citing works

Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome

Dominick, K. C., Andrews, H., Kaufmann, W. E., Berry‐Kravis, E., & Erickson, C. A. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2021.0042 · Cited by 22 · see citing works

Medication use by adolescents and adults with fragile X syndrome

Laxman, D. J., Greenberg, J. S., DaWalt, L. S., Hong, J., Aman, M. G., & Seltzer, M. M. (2017) · Journal of Intellectual Disability Research · doi:10.1111/jir.12433 · Cited by 12 · see citing works

Fragile X Syndrome: A Psychiatric Perspective

Tranfaglia, M. R. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-21649-7_16 · Cited by 14 · see citing works

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome

Berry‐Kravis, E., Sumis, A. M., Hervey, C., & Mathur, S. (2012) · International Journal of Pediatrics · doi:10.1155/2012/843016 · Cited by 54 · see citing works

doi:10.1155/2012/843016 Clinical Study Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome

Berry‐Kravis, E., Sumis, A. M., Hervey, C. M., & Mathur, S. (2016)